Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07016555 · ClinicalTrials.gov registry record · Early Phase 1
Burning Mouth Syndrome: Symptoms and Management
A Early Phase 1 study of Burning Mouth Syndrome, sponsored by University of Massachusetts, Amherst.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07016555 is a Early Phase 1 study of Burning Mouth Syndrome that is actively recruiting participants, run by University of Massachusetts, Amherst. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07016555, a Early Phase 1 study of Burning Mouth Syndrome, is actively recruiting participants, sponsored by University of Massachusetts, Amherst.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Oral cooling spray
Study Locations (1)
Massachusetts
- UMass Amherst - Amherst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2025-12-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07016555
The ClinicalTrials.gov registry entry for NCT07016555 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Burning Mouth Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Oral cooling spray is the first listed.
NCT07016555 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07016555 about?
NCT07016555 is a clinical study titled "Burning Mouth Syndrome: Symptoms and Management". This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment,...
What is the current status of trial NCT07016555?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2025-06-11. Estimated completion is 2025-12-15.
What conditions does trial NCT07016555 study?
This clinical trial studies the following conditions: Burning Mouth Syndrome.
What interventions are being tested in trial NCT07016555?
The interventions under investigation include: Oral cooling spray (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07016555?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07016555 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burning Mouth Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.